Biovie Inc (BIVI)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $12.12M
Last updated: Nov 17, 2026 at 4:24 PM ET
Biovie Inc (BIVI) Stock Chart
Biovie (BIVI) has a latest price of $1.44 on Nov 17, 2026, 62.0% below its 52-week high of $3.79. Its price fell 18.3% over the 12 months through Oct 2026. The month-end price fell 99.9% over the 10 years through Oct 2026, a compound annual decline of 53.1%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $4,375.00 in Apr 2017 and its lowest $1.14 in Jan 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart BIVI with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for BIVI.
Free with a GNG account. No credit card.
Price Performance
The month-end price fell 99.7% over the 3 years through Oct 2026, a compound annual decline of 85.1%.
| Period | Change | Per year |
|---|---|---|
| 1 year | -18.3% | -18.3% |
| 3 years | -99.7% | -85.1% |
| 5 years | -99.8% | -70.2% |
| 10 years | -99.9% | -53.1% |
Price by Year
Its best calendar year was 2020, when the price rose 394.9%, and its weakest was 2025, when it fell 94.2%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.43 | +23.3% |
| 2025 | $1.16 | -94.2% |
| 2024 | $20.00 | -84.1% |
| 2023 | $126.00 | -83.8% |
| 2022 | $777.00 | +72.7% |
| 2021 | $450.00 | -74.0% |
| 2020 | $1,732.00 | +394.9% |
| 2017 | $1,875.00 | -49.2% |
Trading Range
The price is 0.1% above its 50-day average of $1.44 and 5.3% below its 200-day average of $1.52.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.44 | |
| 52-week high | $3.79 | -62.0% |
| 52-week low | $0.82 | +75.6% |
| 50-day average | $1.44 | +0.1% |
| 200-day average | $1.52 | -5.3% |
Price Risk
Over 3 years, its largest fall from a peak was 99.8%.
| Measure | Value |
|---|---|
| 1-year beta | 1.63 |
| Largest fall, 3 years | -99.8% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About BIVI
What is BIVI's 1-year price change?
Biovie's price fell 18.3% over the 12 months through Oct 2026.
What is BIVI's 5-year price change?
Biovie's month-end price fell 99.8% over the 5 years through Oct 2026, a compound annual decline of 70.2%. These figures leave out dividends.
What is BIVI's 52-week high and low?
Biovie's 52-week high is $3.79 and its 52-week low is $0.82. Its latest price of $1.44 on Nov 17, 2026 is 62.0% below the high.
What is BIVI's beta?
Biovie's 1-year beta against the S&P 500 is 1.63, so its price has moved more than the market over the past year.
Is the BIVI chart free?
Yes. Advanced Charting for BIVI is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
BIVI pages: Overview, Charting, Earnings, Forecast, Financials, Competitors